|
1
|
Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis.
|
FASEB J
|
2006
|
2.15
|
|
2
|
Emerging concepts in the pathogenesis of lung fibrosis.
|
Am J Pathol
|
2009
|
2.05
|
|
3
|
An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy.
|
Am J Respir Crit Care Med
|
2013
|
1.84
|
|
4
|
Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses.
|
Biochim Biophys Acta
|
2006
|
1.73
|
|
5
|
Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis.
|
Am J Respir Cell Mol Biol
|
2008
|
1.58
|
|
6
|
Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts.
|
Am J Respir Cell Mol Biol
|
2006
|
1.54
|
|
7
|
Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.
|
Am J Respir Crit Care Med
|
2014
|
1.54
|
|
8
|
Altered DNA methylation profile in idiopathic pulmonary fibrosis.
|
Am J Respir Crit Care Med
|
2012
|
1.47
|
|
9
|
Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts.
|
J Biol Chem
|
2010
|
1.36
|
|
10
|
Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli.
|
Am J Pathol
|
2004
|
1.33
|
|
11
|
Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts.
|
Am J Respir Cell Mol Biol
|
2010
|
1.29
|
|
12
|
Thy-1-integrin alphav beta5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-beta1 activation and myofibroblast differentiation.
|
J Biol Chem
|
2010
|
1.25
|
|
13
|
Myofibroblast differentiation and survival in fibrotic disease.
|
Expert Rev Mol Med
|
2011
|
1.23
|
|
14
|
Thy-1 regulates fibroblast focal adhesions, cytoskeletal organization and migration through modulation of p190 RhoGAP and Rho GTPase activity.
|
Exp Cell Res
|
2004
|
1.20
|
|
15
|
Loss of Thy-1 inhibits alveolar development in the newborn mouse lung.
|
Am J Physiol Lung Cell Mol Physiol
|
2009
|
1.19
|
|
16
|
Roles and regulation of Thy-1, a context-dependent modulator of cell phenotype.
|
Biofactors
|
2009
|
1.12
|
|
17
|
Signaling pathways in the epithelial origins of pulmonary fibrosis.
|
Cell Cycle
|
2010
|
1.10
|
|
18
|
Low intensity shear stress increases endothelial ELR+ CXC chemokine production via a focal adhesion kinase-p38{beta} MAPK-NF-{kappa}B pathway.
|
J Biol Chem
|
2008
|
1.08
|
|
19
|
Getting a grip on Thy-1 signaling.
|
Biochim Biophys Acta
|
2008
|
1.07
|
|
20
|
Absence of Thy-1 results in TGF-β induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts.
|
Lab Invest
|
2011
|
1.04
|
|
21
|
Strategic plan for pediatric respiratory diseases research: an NHLBI working group report.
|
Proc Am Thorac Soc
|
2009
|
1.03
|
|
22
|
Thy-1, via its GPI anchor, modulates Src family kinase and focal adhesion kinase phosphorylation and subcellular localization, and fibroblast migration, in response to thrombospondin-1/hep I.
|
Exp Cell Res
|
2006
|
0.99
|
|
23
|
Thy-1 attenuates TNF-alpha-activated gene expression in mouse embryonic fibroblasts via Src family kinase.
|
PLoS One
|
2010
|
0.98
|
|
24
|
Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.
|
Eur Respir J
|
2014
|
0.97
|
|
25
|
Thrombospondin-1-induced focal adhesion disassembly in fibroblasts requires Thy-1 surface expression, lipid raft integrity, and Src activation.
|
J Biol Chem
|
2004
|
0.96
|
|
26
|
The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis.
|
Mod Pathol
|
2011
|
0.96
|
|
27
|
Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin.
|
Am J Pathol
|
2008
|
0.95
|
|
28
|
Myofibroblast differentiation and enhanced TGF-B signaling in cystic fibrosis lung disease.
|
PLoS One
|
2013
|
0.95
|
|
29
|
Pathogenesis of Interstitial Lung Disease in Children and Adults.
|
Pediatr Allergy Immunol Pulmonol
|
2010
|
0.93
|
|
30
|
Thy-1 signals through PPARγ to promote lipofibroblast differentiation in the developing lung.
|
Am J Respir Cell Mol Biol
|
2012
|
0.91
|
|
31
|
Muscle fatigue: MK2 signaling and myofibroblast differentiation.
|
Am J Respir Cell Mol Biol
|
2007
|
0.86
|
|
32
|
ChILD Family Education.
|
Pediatr Allergy Immunol Pulmonol
|
2010
|
0.85
|
|
33
|
Estimation of airway obstruction using oximeter plethysmograph waveform data.
|
Respir Res
|
2005
|
0.82
|
|
34
|
Thy-1 modulates neurological cell-cell and cell-matrix interactions through multiple molecular interactions.
|
Adv Neurobiol
|
2014
|
0.81
|
|
35
|
Effect of the GPI anchor of human Thy-1 on antibody recognition and function.
|
Lab Invest
|
2013
|
0.81
|
|
36
|
Pulmonary interstitial glycogenosis in a patient ultimately diagnosed with Noonan syndrome.
|
Pediatr Pulmonol
|
2013
|
0.79
|
|
37
|
Diffuse lung disease in children: summary of a scientific conference.
|
Pediatr Pulmonol
|
2013
|
0.79
|
|
38
|
Strategic plan for pediatric respiratory diseases research: an NHLBI working group report.
|
Pediatr Pulmonol
|
2009
|
0.76
|
|
39
|
Biological insights from clinical trials and networks.
|
Am J Respir Crit Care Med
|
2012
|
0.75
|
|
40
|
Diffuse and interstitial lung disease and childhood rheumatologic disorders.
|
Curr Opin Rheumatol
|
2012
|
0.75
|
|
41
|
Round Table Discussion: Children's Interstitial Lung Disease.
|
Pediatr Allergy Immunol Pulmonol
|
2010
|
0.75
|
|
42
|
The (pediatric pulmonary) world is flat. The spread of Internet-based pediatric pulmonary case conferences.
|
Ann Am Thorac Soc
|
2013
|
0.75
|
|
43
|
A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies.
|
bioRxiv
|
2022
|
0.75
|